FICHA FARMACOLÓGICA de Fosamprenavir calcium Contiene la Monografía en distintos idiomas (de la Unión Europea), así como la discusión científica que sustenta su aprobación terapéutica. Para acceder a la monografía en idioma español, hacer doble clik en la sigla (es) en la fila que se sitúa más abajo del centro de la página oficial. Se recuerda que todas las informaciones científico-clínicas, así como técnicas propias de la producción, sólo se publican en idioma inglés. Cerasale. DICIEMBRE 17, 2009.
abrir aquí para acceder al documento EMEA completo:
EPARs for authorised medicinal products for human use - Telzir
Active Substance
Fosamprenavir calcium
International Nonproprietary Name or Common Name
Fosamprenavir
Pharmaco-therapeutic Group
Protease inhibitor
ATC Code
J05AE07
Therapeutic Indication:
Telzir in combination with low dose ritonavir is indicated for the treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infected adults, adolescents and children of 6 years and above in combination with other antiretroviral medicinal products.
In moderately antiretroviral experienced adults, Telzir in combination with low dose ritonavir has not been shown to be as effective as lopinavir / ritonavir. No comparative studies have been undertaken in children or adolescents.
In heavily pretreated patients the use of Telzir in combination with low dose ritonavir has not been sufficiently studied.
In protease inhibitor (PI) experienced patients the choice of Telzir should be based on individual viral resistance testing and treatment history.
Date of issue of Marketing Authorisation valid throughout the European Union
12 July 2004
Orphan medicinal product designation date
Not applicable
EPARs for authorised medicinal products for human use
.png)
No hay comentarios:
Publicar un comentario